These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22359933)

  • 1. [Endotoxinemia and systemic inflammation in pathogenesis of chronic heart failure].
    Egorova EN; Kalinkin MN; Mazur ES
    Patol Fiziol Eksp Ter; 2011; (4):42-6. PubMed ID: 22359933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiocenosis and activity of the inflammatory process in the colon of the patients with chronic cardiac failure].
    Egorova EN; Kuz'mina MI; Mazur VV; Kalinkin MN; Mazur ES
    Klin Med (Mosk); 2012; 90(7):46-8. PubMed ID: 23019975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Features of intestine microbiocenosis and systemic inflammation factors in chronic heart failure patients].
    Egorova EN; Sergeeva SI; Mazur VV; Kalinkin MN; Mazur ES
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (5):72-6. PubMed ID: 22145354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
    Egorova EN; Kuz'mina MI; Mazur VV; Kalinkin MN; Mazur ES; Gorshkova MA
    Klin Lab Diagn; 2012 Dec; (12):13-4. PubMed ID: 23479965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.
    Frantz S; Störk S; Michels K; Eigenthaler M; Ertl G; Bauersachs J; Angermann CE
    Eur J Heart Fail; 2008 Apr; 10(4):388-95. PubMed ID: 18343723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats.
    Xia QG; Na T; Guo YM; Bi YT; Zhang HY; Dai DZ
    Acta Pharmacol Sin; 2007 Feb; 28(2):202-10. PubMed ID: 17241522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
    Jordán A; Roldán V; García M; Monmeneu J; de Burgos FG; Lip GY; Marín F
    J Intern Med; 2007 Sep; 262(3):385-92. PubMed ID: 17697160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.
    Wagner DR; Delagardelle C; Ernens I; Rouy D; Vaillant M; Beissel J
    J Card Fail; 2006 Feb; 12(1):66-72. PubMed ID: 16500583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
    Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
    Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammation and endothelial dysfunction in patients with chronic heart failure].
    Greig D; Castro P; Gabrielli L; Miranda R; Verdejo H; Alcaíno H; Bustos C; Chiong M; Godoy I; Mellado R; García L; Salas D; Vivar R; Vukasovic JL; Concepción R; Díaz-Araya G
    Rev Med Chil; 2008 Jun; 136(6):687-93. PubMed ID: 18769823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
    Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
    J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
    Pawlak K; Pawlak D; Mysliwiec M
    Cytokine; 2005 Jul; 31(1):18-24. PubMed ID: 15896974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.